Global prevalence of polypharmacy among the COVID-19 patients: a comprehensive systematic review and meta-analysis of observational studies

BACKGROUND: Polypharmacy has traditionally been defined in various texts as the use of 5 or more chronic drugs, the use of inappropriate drugs, or drugs that are not clinically authorized. The aim of this study was to evaluate the prevalence of polypharmacy among the COVID-19 patients, and the side...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghasemi, Hooman, Darvishi, Niloofar, Salari, Nader, Hosseinian-Far, Amin, Akbari, Hakimeh, Mohammadi, Masoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427437/
https://www.ncbi.nlm.nih.gov/pubmed/36042531
http://dx.doi.org/10.1186/s41182-022-00456-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427437/
https://www.ncbi.nlm.nih.gov/pubmed/36042531
http://dx.doi.org/10.1186/s41182-022-00456-x

Ejemplares similares